title: mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.
abstract: An mdr1 hammerhead was introduced into two adriamycin-selected multi-drug resistant human lung cell lines both of which over-express p-glycoprotein. Expression of the ribozyme resulted in a decrease in mdr1 mRNA expression and an increase in drug sensitivity in both cell lines. This would suggest that the use of specific ribozymes may represent an effective and specific approach in order to restore cellular sensitivity towards anti-cancer drugs.
authors.affiliation: National Cell and Tissue Culture Centre/BioResearch Ireland, Dublin City University, Ireland.
authors.forename: C
authors.initials: C
authors.lastname: Daly
authors.forename: S
authors.initials: S
authors.lastname: Coyle
authors.forename: S
authors.initials: S
authors.lastname: McBride
authors.forename: L
authors.initials: L
authors.lastname: O'Driscoll
authors.forename: N
authors.initials: N
authors.lastname: Daly
authors.forename: K
authors.initials: K
authors.lastname: Scanlon
authors.forename: M
authors.initials: M
authors.lastname: Clynes
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism / Q000494:pharmacology; D001483:Base Sequence; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D003062:Codon / Q000235:genetics; D004317:Doxorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000494:pharmacology; D005091:Exons / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D009363:Neoplasm Proteins / Q000235:genetics*; D010641:Phenotype; D010957:Plasmids; D016133:Polymerase Chain Reaction; D016372:RNA, Antisense / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D016337:RNA, Catalytic / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D012333:RNA, Messenger / Q000187:drug effects* / Q000378:metabolism; D012334:RNA, Neoplasm / Q000187:drug effects* / Q000378:metabolism; D013379:Substrate Specificity; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014750:Vincristine / Q000494:pharmacology
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D003062:Codon; D009363:Neoplasm Proteins; D016372:RNA, Antisense; D016337:RNA, Catalytic; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin